Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
COPD
Autologous cell therapy improves outcomes in COPD patients in small trial
Treating chronic obstructive pulmonary disease (COPD) patients with their own cells improved outcomes in an early-phase clinical trial, encouraging the researchers to plan a larger study.
September 14, 2023
Using the human voice to detect COVID, COPD
Presenting their findings on Monday at the European Respiratory Society International Congress in Barcelona, Spain, Maastricht University researchers told the congress that their AI model was accurate 89% of the time and was more accurate than lateral flow rapid antigen tests.
September 7, 2022
Grifols promotes free COPD cheek swab test
An estimated 100,000 people in the U.S. have AAT deficiency, the company said. Grifols' AlphaID tests for 14 genetic mutations associated with AAT deficiency, which typically remains undiagnosed even though screening is simple, Grifols said. It takes seconds to perform the test, and results are available within a week.
November 6, 2019
Update on Alzheimer's blood tests | Is time right for AI in pathology? | C-reactive protein tests find role in COPD
Dear LabPulse Member,
July 15, 2019
C-reactive protein tests help curb antibiotic use in acute COPD
In the open-label, randomized study of 653 patients treated in the primary care setting for acute exacerbations of COPD, the rate of self-reported antibiotic use in those whose management was guided by CRP tests was 57%, compared with 77.4% for those managed as usual. The study was led by Dr. Christopher Butler, clinical director of the University of Oxford Primary Care Clinical Trials Unit (N Engl J Med, July 11, 2019, Vol. 381:2, pp. 111-120).
July 10, 2019
Page 1 of 1
